Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 5Unknown 3Terminated 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Genitourinary 4Thoracic 3Head & Neck 3Breast 3NET 2Lymphoid 2Gynecologic 2Endocrine 2CNS 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Positron Emission Tomography Computed Tomography × Breast × Clear all
NCT04343079 2024-01-23

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

University Hospital, Ghent

Phase NA Unknown
100 enrolled
Breast

Breast Neoplasms

NCT05064475 2021-10-01

Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer

Assiut University

Unknown
72 enrolled
Breast

Breast Neoplasms

NCT03094897 2017-04-13

Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics

Wuxi No. 4 People's Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡